[account_shop_links]
CRO Quality Benchmarking – Phase II/III Service Providers (4th edition)
$6,800.00 – $13,600.00
Licensing Options
- SINGLE-USER LICENSE
A Single-User License allows access to an individual user.
- ENTERPRISE-WIDE LICENSE
An Enterprise-Wide License allows access to all employees and sites within an organization.
Report Overview
Industry Standard Research’s (ISR) “ CRO Quality Benchmarking – Phase II/III Service Providers (4th edition)” report provides pharmaceutical sponsors and clinical service providers with an independent and comprehensive analysis of CRO service quality and clinical outsourcing of Phase II/III clinical trial services.
This year’s report includes over 352 service evaluations of 25 CROs across 21 critical characteristics associated with service quality.
What you will learn:
- Performance of 25 Phase II/III CROs, measured across 21 critical dimensions of service quality
- How sponsors make their clinical outsourcing decisions, including which service attributes drive selection
- Attitudes, beliefs, and intentions for future outsourcing
How you can use this report:
- For buyers of clinical research service, this report offers insight into CRO service quality and empowers you to make smarter clinical outsourcing decisions by providing evaluation and selection tools.
- For clinical service providers, this critical report offers insight into your service quality, your competitors’ quality, buyers’ needs, CRO selection criteria, paths to differentiation, and clinical outsourcing trends and forecasts.
Report Contents:
- Outsourcing Behaviors, Attitudes, Beliefs, and Intentions
- Service Provider Scorecards
- Segment Selection Rubrics & CROs to Shortlist
- Service Quality Drill-downs
- Appendix of Charts and Graphs
